Search Results for 'dyadic'

Dyadic’s C1 beats industry-standard antigen in Sanofi Pasteur trials

Dyadic’s C1 beats industry-standard antigen in Sanofi Pasteur trials

October 11, 2015 |

In Florida, Dyadic received the test results from the mice trials in a research program with Sanofi Pasteur indicating that the C1-produced antigen generated an equal, or better, immune response in mice than the industry standard antigen. At the same time, Dyadic joined the EU-funded Zoonoses Anticipation and Preparedness Initiative, a/k/a/ ZAPI, which aims to develop […]

Read More

Dyadic picks up “low 7-figure” sum in professional liability settlement: much more to come?

Dyadic picks up “low 7-figure” sum in professional liability settlement: much more to come?

August 9, 2015 |

In Florida, Dyadic International has reached a settlement with one of the three remaining defendant law firms in its ongoing professional liability litigation. The Agreement with Defendants Moscowitz & Moscowitz, PA, Norman Moscowitz and Jane Moscowitz was fully executed on July 31, 2015. Payment of the confidential settlement amount to the Company by the Moscowitz […]

Read More

Dyadic announces new EU project to demo ethanol from biomass

Dyadic announces new EU project to demo ethanol from biomass

May 13, 2015 |

In Florida, Dyadic announced details regarding 2G BIOPIC, a new advanced biofuels project funded by the European Commission’s Horizon 2020 program. In the 2G BIOPIC project, Dyadic’s subsidiary Dyadic Netherlands B.V. will work in collaboration with Compagnie Industrielle de Matiere Vegetale (“CIMV”) and five other industry partners to develop, construct and operate a large demonstration-scale facility that […]

Read More

Dyadic’s FY 2014 results show decreased revenues, but tripling of gross profit

Dyadic’s FY 2014 results show decreased revenues, but tripling of gross profit

March 16, 2015 |

In Florida, Dyadic has announced positive financial results for FY 2014, including 12% year-over-year increase in revenue and tripling of gross profit (excluding one-time, upfront license fees). Net product related revenue remained flat at $9.8 million. Sales for the period were driven by growth in the starch and alcohol markets, offset by lower sales to […]

Read More

Dyadic: Biofuels Digest’s 2015 5-Minute Guide

Dyadic: Biofuels Digest’s 2015 5-Minute Guide

March 5, 2015 |

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries. Dyadic’s C1 platform technology enables the development and large scale manufacture of low cost […]

Read More

4 Minutes With…Mark Emalfarb, CEO, Dyadic International

4 Minutes With…Mark Emalfarb, CEO, Dyadic International

September 23, 2014 |

For a guy deep in the gene business, ironic that he started off with jeans. Back in the 70s, Dyadic began as a pioneer and leader in providing ingredients used in the stone-washing of blue jeans. Along the way the company developed its pretty awesome C1 fungal microorganism platform that has been licensed by Codexis and Abengoa amongst […]

Read More

Dyadic files SEC Form 10; key milestone in road to reporting company status

Dyadic files SEC Form 10; key milestone in road to reporting company status

August 17, 2014 |

In Florida, Dyadic International filed a Form 10 with the SEC. If accepted by the SEC (they have 60 days to respond with questions), Dyadic will become a fully reporting public company again. For those newer to the scene, Dyadic imploded in 2006-07 over a series of mishaps relating to an Asian venture, which resulted […]

Read More

Dyadic announces commercialization agreement with CIMV

Dyadic announces commercialization agreement with CIMV

August 5, 2014 |

In Florida, Dyadic International announced that it has signed a collaboration agreement to commercialize second generation biofuel and bio-based chemical technology with Compagnie Industrielle de la Matière Végétale (“CIMV”), a pioneer in developing processes for the production of biofuels and bio-based chemicals. CIMV’s patented approach of separating the three main components of plant material allows […]

Read More

Dyadic to develop Bakenzyme enzyme for baking industry

Dyadic to develop Bakenzyme enzyme for baking industry

July 14, 2014 |

In Florida, Dyadic has announced details regarding its new Bakenzyme project. In collaboration with several industry partners, the Bakenzyme project seeks to develop a novel, pure and widely applicable xylanase-oxidase enzyme product for the baking industry. Dyadic’s Chief Operating Officer, Danai Brooks, stated, “The aim of this project is to create an enzyme product that improves […]

Read More

Dyadic rocks Q1– gross profits double, revenue up 20%

Dyadic rocks Q1– gross profits double, revenue up 20%

May 12, 2014 |

In Florida, Dyadic’s gross profit in Q1 of FY2014 has nearly doubled from $520,000 to over $1,000,000 since FY2013, according to the company’s Q1 results announced last week. Revenues also grew 20% in Q1. Regarding the coming months, CEO Mark Emalfarb said, “Dyadic’s technology licensing model is expected to bring us recurring royalty streams in […]

Read More